A share price of Lexicon Pharmaceuticals Inc [LXRX] is currently trading at $0.35, down -9.47%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The LXRX shares have gain 21.22% over the last week, with a monthly amount drifted -52.07%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] stock has seen the most recent analyst activity on March 05, 2025, when Leerink Partners downgraded its rating to a Market Perform and also revised its price target to $1 from $2. Previously, H.C. Wainwright started tracking the stock with Buy rating on June 17, 2024, and set its price target to $10. On April 30, 2024, Leerink Partners initiated with a Outperform rating and assigned a price target of $5 on the stock. Jefferies started tracking the stock assigning a Hold rating and suggested a price target of $3 on March 07, 2023. Piper Sandler initiated its recommendation with a Overweight and recommended $10 as its price target on August 12, 2022. JP Morgan upgraded its rating to Neutral for this stock on January 29, 2021, but kept the price target unchanged to $7. In a note dated January 29, 2021, Wedbush downgraded an Neutral rating on this stock and boosted its target price from $2 to $8.
Lexicon Pharmaceuticals Inc experienced fluctuations in its stock price throughout the past year between $0.28 and $2.83. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Lexicon Pharmaceuticals Inc [NASDAQ: LXRX] shares were valued at $0.35 at the most recent close of the market. An investor can expect a potential return of 1614.29% based on the average LXRX price forecast.
Analyzing the LXRX fundamentals
Trailing Twelve Months sales for Lexicon Pharmaceuticals Inc [NASDAQ:LXRX] were 31.08M which represents 3682.62% growth. Gross Profit Margin for this corporation currently stands at 0.88% with Operating Profit Margin at -40.37%, Pretax Profit Margin comes in at -41.09%, and Net Profit Margin reading is -41.09%. To continue investigating profitability, this company’s Return on Assets is posted at -0.67, Equity is -1.07 and Total Capital is -0.74. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.57.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.3398 points at the first support level, and at 0.3249 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.3698, and for the 2nd resistance point, it is at 0.3849.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Lexicon Pharmaceuticals Inc [NASDAQ:LXRX] is 5.44. Further, the Quick Ratio stands at 5.44, while the Cash Ratio is 0.96. Considering the valuation of this stock, the price to sales ratio is 4.13, the price to book ratio is 0.88.
Transactions by insiders
Recent insider trading involved COATS LONNEL, Former Affiliate, that happened on Aug 15 ’24 when 0.3 million shares were purchased.
